Home Industries Reports Services About Us Publisher Contact us

Hyaluronic Acid Market by Type (Osteoarthritis, Derma Fillers, Ophthalmic, Vesicoureteral)-Global Market Trends & Forecasts Upto 2030

Type: PDF

Status: Syndicate

Categories: Chemical

Report Code : CH23

No. of Pages : 150

The total hyaluronic acid market is anticipated to grow at a CAGR of 7.3% from 2023-2030 and is projected to reach USD 14 billion by 2030. Hyaluronic acid finds it usage in treating joint pains, osteoarthritis, and certain cosmetic surgeries. Globally, the market is expected to be highly driven by the rising demand for hyaluronic acid in medical as well as beauty and cosmetic industries. Increasing incidence of ulcers, growing geriatric population, and rising obesity that results in a number of cases of joint pain and osteoarthritis are the major factors that contribute towards the market growth. Huge R&D in technology towards better health services is anticipated to boost the demand for hyaluronic acid during the forecast period.
In terms of product type, in Osteoarthritis, the five injection therapy accounted for the largest market share in 2023. The five injection course consists of five consecutive weeks and is highly recommended by doctors. By the end of the treatment cycle, the patient or the consumer starts experiencing the effect of the hyaluronic acid therapy. The segment accounted for more than 40% of the global market in 2023, owing to its popularity among both doctors and consumers. Single and three injection cycle account for a lesser market share as these injections are much costlier than five injections and are not very affordable for consumers. However, the single injection therapy is gaining popularity and is expected to witness the highest growth rate in future, due to the preference of consumers for short term treatment, along with it being quite convenient for them.


Dermal fillers was observed as the largest market segment in 2023. The increasing desire of the consumer to maintain their beauty and looks drives the market for the dermal filler segment. Hyaluronic acid injections are used to improve the skin's contour and reduce depressions in the skin caused by scars, injury, or lines. Coupled with the rising trend of cosmetic surgery all the other factors contribute heavily to the market growth of dermal fillers and hyaluronic acid as a whole.
In terms of region, North America was the largest market for hyaluronic acid followed by Europe. Some of the major players such as Anika Therapeutics, Sanofi Genzyme, Salix Pharmaceuticals, etc., in North America and their highly competing strategies to provide the consumer with cost-effective products makes North America one of the most favoured markets for hyaluronic acid. The awareness of such treatment makes this region a favourable market for hyaluronic acid than the Asia-Pacific market. 


Recently, a new trend of usage of combination products and the pipelines of major manufacturers in the hyaluronic acid products market having a combo of corticosteroid and hyaluronic acid-based injections has been observed. This innovative combination provides a pain relieving effect of corticosteroids with the long-lasting influence of hyaluronic acids.
Major companies are engaged in extensive R&D to develop innovative and effective products. In 2023, Bioventus, an orthobiologic solutions provider, entered into a multi-year agreement with Institut Biochimique SA (IBSA) from Switzerland, to secure the U.S. distribution rights for GELSYN-3 (a three-injection, hyaluronic acid product for pain relief related to osteoarthritis (OA) of the knee). In January 2023, Anika Therapeutics expanded its collaboration with the Institute for Applied Life Sciences (IALS) at the University of Massachusetts Amherst to develop an innovative therapy for rheumatoid arthritis. Some of the major players that operate in the industry are Sanofi Genzyme, Salix Pharmaceuticals, Shiseido, Ferring B.V., Lifecore Bio-Medical, LLC, LG Life Sciences, Allergan, Galderma and Seikagaku Corporation, & others.

Request For List of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution

1 Introduction     
 1.1 Goal & Objective    
 1.2 Report Coverage    
 1.3 Supply Side Data Modelling & Methodology    
 1.4 Demand Side Data Modelling & Methodology    
      
2 Executive Summary     
      
3 Market Outlook      
 3.1 Introduction    
 3.2 Current & Future Outlook    
 3.3 DROC    
  3.3.1 Drivers   
   3.3.1.1 Demand Drivers  
   3.3.1.2 Supply Drivers  
  3.3.2 Restraints   
  3.3.3 Opportunities   
  3.3.4 Challenges   
 3.4 Market Entry Matrix    
 3.5 Market Opportunity Analysis    
 3.6 Market Regulations    
 3.7 Pricing Mix    
 3.9 Value Chain & Ecosystem    
 3.8 Key Customers    
      
 Demand Side Analysis     
 4.1 Hyaluronic Acid Market by Type    
  4.1.1 Osteoarthritis   
   4.1.1.1 Single Injection  
   4.1.1.2 Three Injection  
   4.1.1.3 Five Injection  
  4.1.2 Dermal Fillers   
  4.1.3 Ophthalmic   
  4.1.4 Vesicoureteral   
      
 Hyaluronic Acid Market Analysis, By Region       
 6.1 North America    
  6.1.1 U.S.   
  6.1.2 Canada   
  6.1.3 Mexico   
 6.2 Europe     
  6.2.1 Germany    
  6.2.2 Italy   
  6.2.3 France   
  6.2.4 Spain   
  6.2.5 UK   
  6.2.6 Poland   
  6.2.7 Turkey   
  6.2.8 Rest of Europe   
 6.3 Asia Pacific    
  6.3.1 China   
  6.3.2 Japan   
  6.3.3 India   
  6.3.4 Malyasia   
  6.3.5 Thailand   
  6.3.6 Idonesia   
  6.3.7 Rest of APAC   
 6.4 Middle East & Africa    
  6.4.1 Saudi Arabia   
  6.4.2 UAE   
  6.4.5 Rest Of Middle East & Africa   
 6.5 South America    
  6.5.1 Brazil   
  6.5.3 Argentina   
  6.5.4 Rest of South America   
      
 Supply Side Analysis     
 7.1 Strategic Benchmarking    
 7.1 Market Share Analysis    
 7.1 Key Players     
  7.3.1 Genzyme Corporation   
  7.3.2 Sanofi   
  7.3.3 Shiseido   
  7.3.4 Ferring B.V.   
  7.3.5 Lifecore Bio-Medical, LLC   
  7.3.6 LG Life Sciences   
  7.3.7 Sanofi   
  7.3.8 Ankita Therapeutics   
  7.3.9 Allergan   
  7.3.10 Salix Pharmaceuticals   
  7.3.11 Galderma   
  7.3.12 Seikagaku Corporation & Others   

SDMR employs a three way data triangulation approach to arrive at market estimates. We use primary research, secondary research and data triangulation by top down and bottom up approach 

Secondary Research:
Our research methodology involves in-depth desk research using various secondary sources. Data is gathered from association/government publications/databases, company websites, press releases, annual reports/presentations/sec filings, technical papers, journals, research papers, magazines, conferences, tradeshows, and blogs.

Key Data Points through secondary research-
Macro-economic data points
Import Export data
Identification of major market trends across various applications
Primary understanding of the industry for both the regions
Competitors analysis for the production capacities, key production sites, competitive landscape
Key customers
Production Capacity 
Pricing Scenario
Cost Margin Analysis                                                                                                                                                                                       
Primary Research:
After collecting the secondary data, our team conducts primary interviews to validate the accuracy of the information. Primary interviews are conducted across entire value chain from raw material suppliers to end users. The primary interview is mainly conducted with the Presidents, CEOs, Vice Presidents, Directors, General Managers, Product Manager, Sales Manager, Marketing Manager, Business Development Manager.

Key Data Points through primary research-
Major factors driving the market and its end application markets
Comparative analysis and customer analysis
Regional presence 
Collaborations or tie-ups
Annual Production, and sales
Profit Margins
Average Selling Price

Data Triangulation:
Data triangulation is done using top down and bottom approaches. However, to develop accurate market sizing estimations, both the methodologies are used to accurately arrive at the market size. 

Global United Research

Report Code

CH23

Single User

US$ 4999

Multi User

US$ 6999

Corporate User

US$ 7000

Related Reports

Hyaluronic Acid Market by Type (Osteoarthritis, De...

RD Code : CH23